|
Volumn 23, Issue 6 SUPPL. 15, 1996, Pages 43-48
|
Paclitaxel-containing high-dose chemotherapy: The University of Colorado experience
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
ACUTE KIDNEY FAILURE;
ACUTE RESPIRATORY FAILURE;
ADULT;
ARTICLE;
BRAIN METASTASIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
GERM CELL TUMOR;
HEMATOPOIETIC STEM CELL;
HUMAN;
HYPERBILIRUBINEMIA;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER METASTASIS;
MALE;
MAXIMUM PERMISSIBLE DOSE;
MUCOSA INFLAMMATION;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
VULVA CARCINOMA;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
EID: 0030497351
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (25)
|